Male contraceptives are methods of preventing pregnancy that primarily involve the male physiology. The most common kinds of male contraception include condoms, withdrawal / pulling out, outercourse, and vasectomy. In domestic animals, castration is commonly used for contraception. Other forms of male contraception are in various stages of research and development. These include methods like RISUG/VasalGel (which has completed a small phase II clinical trial in humans in India) and ultrasound (with results so far obtained in experimental animals).
Vasectomy is a surgical procedure for male sterilization and/or permanent birth control. During the procedure, the vasa deferentia of a man are severed, and then tied/sealed in a manner such to prevent sperm from entering into the seminal stream (ejaculate). Vasectomies are usually performed in a physician's office or medical clinic. CDC research has estimated there is a probability of 11 failures per 1,000 procedures over 2 years; half of the failures occurred in the first three months after the vasectomy, and no failures occurred after 72 weeks. Due to the presence of sperm retained beyond the blocked vasa deferentia, vasectomies only become effective about three months following the operation.
Dioscorides, ca. 40 A.D., described the contraceptive property of hemp seeds (Cannabis sativa) and rue (Ruta graveolens) in De Materia Medica, a text widely used into medieval times. One test in rats (20 milligrams of the 80% ethanol extract) found that these reduced sperm count by more than half. In medieval Persia (and in other traditions as cited) these herbs were used for male contraception, as well as Gossypium herbaceum (Malvaceae), Cyperus longus (Cyperaceae), Vitex pseudonegundo (Verbenaceae), Chenopodium ambrosioides (Chenopodiaceae), Aristolochia indica (Aristolochiaceae), Punica granatum (Punicaceae), and Sarcostemma acidum (Asclepiadaceae). However, the compound isolated from Gossypium, as well as other cotton seeds and okra (gossypol) has been abandoned for contraceptive use because it was found to cause permanent infertility in ten to twenty percent of users.
In Indian traditional medicine, uses of the neem tree were described in Ayurvedic medicine, by Sushruta and in the Rasarathasamucchaya, Sarangadhara, Bhavaprakasha and Bhisagya Ratnavali. Held traditionally to have antifertility effects, its leaves were demonstrated to reduce pregnancy rate and litter size in a test of male rats.
In 2002, researchers fed extracts from the seeds of papaya fruits (Carica papaya) to monkeys. Subsequently, the monkeys had no sperm in their ejaculate. Traditionally used for contraception, papaya seeds had no apparent ill effects on the testes or other organs of rats tested with a long-term treatment.
Heat-based contraception, dating in concept to the writings of Hippocrates, involves heating the testicles to prevent the formation of sperm. Requiring the maintenance of testes at 116 °F (47 °C) (just below the threshold of pain) for 45 minutes, it is not a widely appealing technique, but a variant employing ultrasound has been under investigation.
A goal of research is to develop a reversible male contraceptive, either pharmaceutical, surgical or other.
Two delivery methods are currently under active study: male hormonal contraceptives that can be taken in pill form by mouth, similar to the existing oral contraceptive pill for women. and male hormonal injections.
- Gossypol, an extract of cotton, has been studied as a male contraceptive pill. It decreased sperm production; however this is permanent in 20% of people.
- Inhibition of chromatin remodeling by binding to a pocket on BRDT has been shown to produce reversible sterility in male mice. JQ1, a selective BRDT inhibitor which acts in this manner, is currently under development as a non-hormonal male contraceptive drug. It effectively blocks the production of sperm by the testes, and lacks the adverse effects of previously researched hormonal contraceptives for men.
- Calcium channel blockers such as nifedipine may cause reversible infertility by altering the lipid metabolism of sperm so that they are not able to fertilize an egg. Recent Research at Israel's Bar-Ilan University show that as of June 2010, such a pill may be five years away. Testing it on mice has been found to be effective, with no side effects.
- A compound that interferes with the vitamin A pathway has been shown to render male mice sterile for the course of the treatment without affecting libido. Once taken off the compound, the mice continued to make sperm. The mechanism of action includes blocking the conversion of vitamin A into its active form retinoic acid which binds to retinoic receptors which is needed to initiate sperm production. This can be done, for instance, by blocking an aldehyde dehydrogenase called RALDH3 (ALDH1A2), which converts retinaldehyde into retionic acid in testes. Past attempts to do this failed because the blocking compounds were not sufficiently specific and also blocked other aldehyde dehydrogenases, such as those responsible for the alcohol metabolism, causing serious side effects. Another way is blocking retionic receptors themselves, although it can also have serious side effects.
- Adjudin, a non-toxic analog of lonidamine has been shown to cause reversible infertility in rats. The drug disrupts the junctions between nurse cells (Sertoli cells) in the testes and forming spermatids. The sperm are released prematurely and never become functional gametes. A new targeted delivery mechanism has made Adjudin much more effective.
- Gamendazole, a derivative of lonidamine, shows semi-reversible infertility in rats. The mechanism of action is thought to be disruption of Sertoli cell function, resulting in decreased levels of inhibin B.
- Multiple male hormonal contraceptive protocols have been developed. One is a combination protocol, involving injections of Depo-Provera to prevent spermatogenesis, combined with the topical application of testosterone gel to provide hormonal support. A similar proposal consists of yearly subdermal implant administering a synthetic testosterone compound (7α-methyl-19-nortestosterone) combined with regular injections of Depo-Provera.  The implant alone (without Depo-Provera injections) has been shown to already sufficiently reduce sperm count in most of the subjects given the highest tested dosage in a Phase II trial.  Another is a monthly injection of testosterone undecanoate, which recently performed very well in a Phase III trial in China.
- Phenoxybenzamine has been found to block ejaculation, which gives it the potential to be an effective contraceptive. Studies have found that the quality of the semen is unaffected and the results are reversible by simply discontinuing the treatment.
- RISUG consists of injecting a polymer gel, styrene maleic anhydride in dimethyl sulfoxide, into the vas deferens. The polymer has a positive charge, and when negatively charged sperm pass through the vas deferens, the charge differential severely damages the sperm. A second injection washes out the substance and restores fertility. As of 2011[update], RISUG is in Phase III of human testing in India and has been patented in India, China, Bangladesh and the United States. Vasalgel is a brand name of polymer gel injection that is being tested in the United States, rabbit testing has been completed and primate testing has shown positive results so far, leading to predictions of human trials in 2015.
- Vas-occlusive contraception consists of partially or completely blocking the vas deferens, the tubes connecting the epididymis to the urethra. While a vasectomy removes a piece of each vas deferens, the intra vas device (IVD) and other injectable plugs only block the tubes until the devices are removed. The U.S. Food and Drug Administration (FDA) approved human clinical trials for the intra-vas device in 2006.
- Research on the safety and effectiveness of using ultrasound treatments to kill sperm has undergone since the idea originally came about following experiments in the 1970s by Mostafa S. Fahim who noticed ultrasound killed microbes and decreased fertility. As of 2012 a study conducted on rats found that two 15-minute treatments of ultrasound delivered 2 days apart in a warm salt bath effectively lowered their sperm count to below fertile levels. Another small study involved dogs, and found that after three ultrasound applications the dogs' ejaculate contained no sperm. Further experiments on its effectiveness on humans, the longevity of the results, and its safety have yet to be conducted.
- Miglustat (Zavesca or NB-DNJ) is a drug approved for treatment of several rare lipid storage disorder diseases. In mice, it provided effective and fully reversible contraception. But it seems this effect was only true for several genetically related strains of laboratory mice. Miglustat showed no contraceptive effect in other mammals.
- Trestolone is an anabolic steroid that has been shown to significantly reduce sperm count, but is not currently being pursued as a marketable birth control method.
- Silodosin, an α1-adrenoceptor antagonist with high uroselectivity, approved by the FDA to treat Benign Prostatic Hyperplasia (BPH), has been shown to decrease sperm count when taken in at 5 times normal doses.
- Glasier A (November 2010). "Acceptability of contraception for men: a review". Contraception 82 (5): 453–6. doi:10.1016/j.contraception.2010.03.016. PMID 20933119.
- Guha, Sujoy; Singh G; Ansari S; Kumar S; Srivastava A; Koul V; Das HC; Malhotra RL; Das SK. (Oct 1997). "Phase II clinical trial of a vas deferens injectable contraceptive for the male". Contraception 56 (4): 245–50. doi:10.1016/s0010-7824(97)00142-x. PMID 9408706.
-  Expanding Options for Male Contraception. Planned Parenthood Advocates of Arizona. August 8, 2011. Retrieved April 1, 2012.
- Tsuruta, James K.; Dayton PA, Gallippi CM, O'Rand MG, Streicker MA, Gessner RC, Gregory TS, Silva EJ, Hamil KG, Moser GJ, Sokal DC. (30 January 2012). "Therapeutic ultrasound as a potential male contraceptive: power, frequency and temperature required to deplete rat testes of meiotic cells and epididymides of sperm determined using a commercially available system". Reprod Biol Endocrinol. 10 (7): 7. doi:10.1186/1477-7827-10-7. PMC 3340307. PMID 22289508.
- <http://www.plannedparenthood.org/health-topics/birth-control-4211.htm >.
- Hatcher RA, Trussel J et al. (2000). Contraceptive Technology (18th ed.). New York: Ardent Media. ISBN 0-9664902-6-6.
- Dioscorides (ca. 40 A.D.). De Materia Medica. Check date values in:
|date=(help) (translated by Goodyer (1655), modified and published 1933 by Robert Gunther). The herbs are said to "extinguish conception".
- Sailani MR, Moeini H; Moeini (July 2007). "Effect of Ruta graveolens and Cannabis sativa alcoholic extract on spermatogenesis in the adult wistar male rats". Indian Journal of Urology 23 (3): 257–60. doi:10.4103/0970-1591.33720. PMC 2721602. PMID 19718326.
- Hadley MA, Lin YC, Dym M. (1981). "Effects of gossypol on the reproductive system of male rats". J Androl. (2): 190–9.
- Khaleghi Ghadiri M, Gorji A; Gorji (February 2004). "Natural remedies for impotence in medieval Persia". International Journal of Impotence Research 16 (1): 80–3. doi:10.1038/sj.ijir.3901153. PMID 14963476.
- Conway GA, Slocumb JC; Slocumb (October 1979). "Plants used as abortifacients and emmenagogues by Spanish New Mexicans". Journal of Ethnopharmacology 1 (3): 241–61. doi:10.1016/S0378-8741(79)80014-8. PMID 232204.
- Pakrashi A, Pakrasi PL; Pakrasi (April 1977). "Antispermatogenic effect of the extract of Aristolochia indica Linn on male mice". Indian Journal of Experimental Biology 15 (4): 256–9. PMID 914334.
- Prakash AO, Saxena V, Shukla S et al. (1985). "Anti-implantation activity of some indigenous plants in rats". Acta Europaea Fertilitatis 16 (6): 441–8. PMID 3832714.
- Venma PK, Sharma A, Mathur A et al. (March 2002). "Effect of Sarcostemma acidum stem extract on spermatogenesis in male albino rats". Asian Journal of Andrology 4 (1): 43–7. PMID 11907627.
- Coutinho EM (Apr 2002). "Gossypol: a contraceptive for men". Contraception 65 (4): 259–63. doi:10.1016/S0010-7824(02)00294-9. PMID 12020773.
- Deshpande VY, Mendulkar KN, Sadre NL; Mendulkar; Sadre (July 1980). "Male antifertility activity of Azadirachta Indica in mice". Journal of Postgraduate Medicine 26 (3): 167–70. PMID 7205685.
- Zhen QS, Ye X, Wei ZJ; Ye; Wei (February 1995). "Recent progress in research on Tripterygium: a male antifertility plant". Contraception 51 (2): 121–9. doi:10.1016/0010-7824(94)00018-R. PMID 7750290.
- Lohiya NK, Manivannan B, Mishra PK et al. (Mar 2002). "Chloroform extract of Carica papaya seeds induces long-term reversible azoospermia in langur monkey". Asian J Androl. 4 (1): 17–26. PMID 11907624.
- Goyal, S.; Manivannan, B.; Ansari, A.; Jain, S.; Lohiya, N. (2010). "Safety evaluation of long term oral treatment of methanol sub-fraction of the seeds of Carica papaya as a male contraceptive in albino rats.". Journal of Ethnopharmacology 127 (2): 286–291. doi:10.1016/j.jep.2009.11.007. PMID 19914367.
- "Heat Methods of Male Contraception". Male Conception Information Project.
- "Male hormonal contraception.". Am J Obstet Gynecol 190 (4 Suppl): S60–8. Apr 2004. doi:10.1016/j.ajog.2004.01.057. PMID 15105800.
- Coutinho, EM (Apr 2002). "Gossypol: a contraceptive for men.". Contraception 65 (4): 259–63. doi:10.1016/s0010-7824(02)00294-9. PMID 12020773.
- "A male contraceptive pill in the making?". Retrieved 17 August 2012.
- Matzuk MM, McKeown MR, Filippakopoulos P et al. (August 2012). "Small-Molecule Inhibition of BRDT for Male Contraception". Cell 150 (4): 673–684. doi:10.1016/j.cell.2012.06.045. PMC 3420011. PMID 22901802.
- O'Rand, MG; EE Widgren; P Sivashanmugam; RT Richardson; SH Hall; FS French; CA Vande Voort; SG Ramachandra; V Ramesh; A Jagannadha Roa (2004). "Reversible immunocontraception in male monkeys immunized with Eppin". Science 306 (5699): 1189–90. Bibcode:2004Sci...306.1189O. doi:10.1126/science.1099743. PMID 15539605.
- Hershlag A, Cooper GW, Benoff S; Cooper; Benoff (March 1995). "Pregnancy following discontinuation of a calcium channel blocker in the male partner". Human Reproduction 10 (3): 599–606. PMID 7782439.
- Parry, Wynne "New Male Birth Control Concept Shows Promise", LiveScience, June 4, 2011, accessed June 6, 2011.
- Chung, SS; Wang, X; Roberts, SS; Griffey, SM; Reczek, PR; Wolgemuth, DJ (2011). "Oral Administration of a Retinoic Acid Receptor Antagonist Reversibly Inhibits Spermatogenesis in Mice". Endocrinology 152 (6): 2492–2502. doi:10.1210/en.2010-0941. PMC 3100616. PMID 21505053.
- Sam Kean (2012). "Reinventing the Pill: Male Birth Control". Science 338 (6105): 318–320. doi:10.1126/science.338.6105.318. PMID 23087225.
- Mruk DD, Cheng CY; Cheng (October 2004). "Sertoli-Sertoli and Sertoli-germ cell interactions and their significance in germ cell movement in the seminiferous epithelium during spermatogenesis". Endocrine Reviews 25 (5): 747–806. doi:10.1210/er.2003-0022. PMID 15466940.
- Mruk DD, Wong CH, Silvestrini B, Cheng CY; Wong; Silvestrini; Cheng (November 2006). "A male contraceptive targeting germ cell adhesion". Nature Medicine 12 (11): 1323–8. doi:10.1038/nm1420. PMID 17072312.
- Tash, Joseph; Attardi, B; Hild, SA; Chakrasali, R; Jakkaraj, SR; Georg, GI (July 2008). "A Novel Potent Indazole Carboxylic Acid Derivative Blocks Spermatogenesis and Is Contraceptive in Rats after a Single Oral Dose". Biology of Reproduction 78 (6): 1127–1138. doi:10.1095/biolreprod.106.057810. PMID 18218612.
- Finn, Robert (May 2007). "Male Contraceptive Methods Are in the Pipeline". Ob.Gyn. News 42 (9): 8. doi:10.1016/S0029-7437(07)70395-6 (inactive 2015-01-09).
- Nuzzo R (2006) Beyond condoms: male hormonal contraceptives may finally be on track. Los Angeles Times, 16 October.
- Sigrid von Eckardstein; Gabriela Noe; Vivian Brache et al. (November 2003). "A clinical trial of 7α-methyl-19-nortestosterone implants for possible use as a long-acting contraceptive for men". The Journal of Clinical Endocrinology and Metabolism 88 (11): 5232–9. doi:10.1210/jc.2002-022043. PMID 12574181.
- Gu YQ, Wang XH, Xu D et al. (February 2003). "A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men". The Journal of Clinical Endocrinology and Metabolism 88 (2): 562–8. doi:10.1210/jc.2002-020447. PMID 12574181.
- Gu Y, Liang X, Wu W et al. (June 2009). "Multicenter contraceptive efficacy trial of injectable testosterone undecanoate in Chinese men". The Journal of Clinical Endocrinology and Metabolism 94 (6): 1910–5. doi:10.1210/jc.2008-1846. PMID 19293262.
- Turner TT, Johnston DS, Jelinsky SA; Johnston; Jelinsky (May 2006). "Epididymal genomics and the search for a male contraceptive". Molecular and Cellular Endocrinology 250 (1–2): 178–83. doi:10.1016/j.mce.2005.12.042. PMID 16458420.
- Gottwald U, Davies B, Fritsch M, Habenicht UF; Davies; Fritsch; Habenicht (May 2006). "New approaches for male fertility control: HE6 as an example of a putative target". Molecular and Cellular Endocrinology 250 (1–2): 49–57. doi:10.1016/j.mce.2005.12.024. PMID 16442214.
- Kjaergaard N, Kjaergaard B, Lauritsen JG; Kjaergaard; Lauritsen (June 1988). "Prazosin, an adrenergic blocking agent inadequate as male contraceptive pill". Contraception 37 (6): 621–9. doi:10.1016/0010-7824(88)90008-X. PMID 2899490.
- Finn, Robert (May 1, 2007). "Male Contraceptive Methods Are in the Pipeline" (PDF). Ob. Gyn. News 42 (9): 28.
- Murray, Rheana (30 January 2012). "Ultrasound kills sperm, could be the future of male birth control: study". Daily News. Retrieved 30 January 2012.
- Amory JK, Muller CH, Page ST et al. (March 2007). "Miglustat has no apparent effect on spermatogenesis in normal men". Human Reproduction (Oxford, England) 22 (3): 702–7. doi:10.1093/humrep/del414. PMID 17067996.